High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy

Elizabeth S. Aby, Tsung Hua Shen, Meena N. Murugappan, David D. Stenehjem, Thomas M. Leventhal

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy'. Together they form a unique fingerprint.

Medicine & Life Sciences